Publicatii

Articole publicate în reviste indexate ISI

Vezi mai mult

1. Isac T, Isac S, Rababoc R, Cotorogea M, Iliescu L. Epigenetics in inflammatory liver diseases: A clinical
   perspective (Review). Exp Ther Med. 2022 May;23(5):366. doi: 10.3892/etm.2022.11293. Epub 2022
   Apr 4.
2. Bacinschi X, Popescu GC, Zgura A, Gales L, Rodica A, Mercan A, Serban D, Haineala B, Toma L,
   Iliescu L. A Real-World Study to Compare the Safety and Efficacy of Paritaprevir/Ombitasvir/ Ritonavir
   and Dasabuvir, with or without Ribavirin, in 587 Patients with Chronic Hepatitis C at the Fundeni Clinical
   Institute, Bucharest, Romania. Med Sci Monit. 2022 Jul 5;28:e936706. doi: 10.12659/MSM.936706.
3. Gheorghe L, Preda C, Trifan A, Manuc M, Stanciu C, Istratescu D, Popescu CP, Diculescu MM, Tieranu
   CG, Manuc T, Stroie TG, Iacob SM, Iliescu L. Real World Efficacy and Safety of Sofosbuvir +
   Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to
   DAAs Therapy. J Gastrointestin Liver Dis. 2022 Dec 17;31(4):437-443. doi: 10.15403/jgld-4472.
4. Isac T, Isac S, Ioaniţescu S, Mihaly E, Tănăsescu MD, Bălan DG, Tulin A, Iliescu L. Dynamics of
   serum α‑fetoprotein in viral hepatitis C without hepatocellular carcinoma
   Exp Ther Med. 2021 Jul;22(1):749. doi: 10.3892/etm.2021.10181. Epub 2021 May 12.
5. Trifan A, Stanciu C, Iliescu L, Sporea I, Baroiu I, Diculescu M, Luca MC, Miftode E, Cijeveschi C, Mihai
   C, Sparchez ZA, Pojoga C, Streinu-Cercel A, Gheorghe L. Effectiveness of 8- and 12-Week Treatment
   with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life
   Setting in Romania: the AMETHYST Study. J. Gastrointestin Liver Dis, March 2021 Vol. 30 No 1, pag
   88-93 DOI: http://dx.doi.org/10.15403/jgld-3373
6. Guler-Margaritis S, Mercan-Stanciu A, Toma L, Rusie D, Isac T, Dodot M, Zgura A, Bacalbasa N,
   Haineala B, Badiu DC, Serban D, Iliescu EL. COVID-19 Mid-term Impact on Hepatocellular
   Carcinoma in Patients With Hepatitis C Chronic Infection (2021) In Vivo. 2021 Nov-
   Dec;35(6):3377-3383. doi: 10.21873/invivo.12636.
7. Iliescu EL, Mercan-Stanciu A, Toma L. Safety and efficacy of direct-acting antivirals for chronic hepatitis
   C in patients with chronic kidney disease. BMC Nephrol. 2020 Jan 16;21(1):21. doi: 10.1186/s12882-
   020-1687-1.
8. Toma L, Stanciu AM, Zgură A, Bacalbaşa N, Diaconu C, Iliescu L. Electrocardiographic Changes
   in Liver Cirrhosis-Clues for Cirrhotic Cardiomyopathy. MEDICINA-LITHUANIA. 2020 Feb
   10;56(2).
9. Pop CS, Preda CM, Mănuc M, Gheorghe LS, Istrătescu D, Chifulescu AE, Voiosu T, Diculescu M,
   Tieranu C, Iliescu L. Occurrence and recurrence of hepatocellular carcinoma in patients with
   HCV genotype 1b related cirrhosis treated with Ledipasvir plus Sofosbuvir +/- Ribavirin. J
   Gastrointestin Liver Dis. 2020 Dec 13;29(4):690-691. doi: 10.15403/jgld-3148.
10. Iliescu L, Toma L, Mercan-Stanciu A, Grumeza M, Dodoţ M, Isac T, Ioanițescu S. Budd-Chiari
    syndrome – various etiologies and imagistic findings. A pictorial review. Med Ultrason 2019: vol
    21, no. 3, 344-348 . DOI: 10.11152/mu-1921
11. Iliescu L, Toma L, Mercan-Stanciu A, Grumeza M, Ioanițescu S. Contrast-Enhanced Ultrasonography in
    the Diagnosis of Portal Vein Thrombosis: A Pictorial Review. Ultrasound Q. 2019 Volume 35 – Issue 4 – p
    311-315 doi: 10.1097/RUQ.0000000000000451
12. Zgura A, Grasu MC, Dumitru RL, Toma L, Iliescu L, Baciu C. An Investigative Analysis of Therapeutic
    Strategies in Hepatocellular Carcinoma: A Raetrospective Examination of 23 Biopsy-Confirmed Cases
    Emphasizing the Significance of Histopathological Insights. Cancers (Basel). 2024 May 17;16(10):1916.
    doi: 10.3390/cancers16101916.
13. Iliescu L, Herlea V, Toma L, Orban C. Association Between Chronic HCV Hepatitis,
    Membranoproliferative Glomerulopathy And Cutaneous Sarcoidosis, J Gastrointestin Liver Dis. 2015
    Mar;24(1):8. doi: 10.15403/jgld.2014.1121.lil.
14. Iliescu L, Ioanițiescu S, Toma L, Orban C. Spontaneous portohepatic venous shunt:
    ultrasonographic aspect. Ultrasound Q. 2015 Jun; 31(2):141-4. doi:
    10.1097/RUQ.0000000000000148
15. Iliescu L. Toma L, Mînzală G, Orban C. Acute Hepatitis After Methimazole.Acta Endo (Buc) 2014 10:267-272 doi: 10.4183/aeb.2014.267 IF: 0.411
16. Savu C, Petreanu C, Melinte A, Posea R, Bălescu I, Iliescu L, Diaconu C, Galie N, Bacalbaşa N.
    Persistent Left Superior Vena Cava – Accidental Finding. In Vivo. 2020 Mar-Apr;34(2):935-941
17. Isac, T; Droc, G; Klimko, A; Cotorogea-Simion, M; Dobre, M; Milanesi; Cucu, N; Balcangiu-Stroescu, AE;
    Iliescu, L; Isac, S. Epigenetic Modulation in Viral Hepatitis C Infected Patients after Successful Therapy.
    Biointerface Research in Applied Chemistry; JUN 15 2023, DOI10.33263/BRIAC133.213
18. Droc G, Istrate M, Mercan-Stanciu A, Dodot M, Isac T, Toma L, Zgura A, Trifan A, Serbanica AN, Iliescu L,
    Micu L. Safety and Efficacy of Direct-acting Antiviral Therapies for Chronic HCV Infection in Hemodialysis
    Patients. In Vivo. 2022 Nov-Dec;36(6):2918-2922. doi: 10.21873/invivo.13033.
19. Bacinschi X, Mercan-Stanciu A, Toma L, Zgura A, Bacalbasa N, Ifrim CP, Diaconu C, Iliescu L, Toma RV.
    Glycemic Control in Patients Undergoing Treatment With Paritaprevir/Ombitasvir/Ritonavir and Dasabuvir
    for Chronic Hepatitis C Infection. In Vivo. 2022 May-Jun;36(3):1438-1443. doi: 20.21873/invivo.12849.
20. Braşoveanu V, Romanescu D, Diaconu C, Iliescu L, Stiru O, Brezean I, Belu E, Savu C, Savu C, Bratu O,
    Gorecki G, Pop L, Bălescu I, Bacalbaşa N. Hepatic artery reconstruction after extended resection for
    borderline resectable pancreatic head cancer: A case report. Exp Ther Med. 2021 Jan;21(1):87. doi:
    10.3892/etm.2020.9518. Epub 2020 Nov 26.
21. Trifănescu OG, Galeş LN, Serbănescu GL, Zgură AF, Iliescu L, Mehedinţu C, Anghel RM. Long-
    term oncological outcome in patients with cervical cancer after 3 trimodality treatment (radiotherapy,
    platinum-based chemotherapy, and robotic surgery). Medicine (Baltimore). 2021 Apr
    2;100(13):e25271. doi: 10.1097/MD.0000000000025271.
22. Gheorghe LS, Preda C, Iliescu L, Istrătescu D, Chifulescu AE, Pop CS, Trifan A, Stanciu C, Diculescu M,
    Voiosu T, Baicus C, Tugui L, Iacob S, Tieranu C, Meianu C, Mănuc M. Efficacy and Safety of
    Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and
    Hepatitis C Infection: a Cohort Study. J Gastrointestin Liver Dis. 2020 Sep 9;29(3):385-390. doi:
    10.15403/jgld-2448.
23. Voiculescu M, Iliescu L, Ionescu C, Micu L, Ismail G, Zilişteanu D, Rădăşan A, Micu G, Pertache I. A
    cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and
    South-Eastern regions of Romania.J Gastrointestin Liver Dis. 2010 Mar; 19(1):43-8

Articole publicate în reviste indexate în baze de date internaționale

Vezi mai mult

1. Stancu G, Iliescu EL. The Influence of Liver Transplant on Serum Cholinesterase Levels: A Case
   Report. Cureus 15(1): e33761. doi:10.7759/cureus.33761
2. Rusie D, Mercan Stanciu A, Toma L, Iliescu L. Correlation Between Serum Alpha-Fetoprotein and
   Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals. Cureus
   14(4): e24506. doi:10.7759/cureus.24506
3. Mercan-Stanciu A, Isac T, Rababoc R, Rusie D, Toma L, Vacaroiu IA, Tulin R, Iliescu L. Multimodal
   Treatment of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection Treated With Direct-
   Acting Antivirals. Cureus 14(5): e25487. doi:10.7759/cureus.25487
4. Boeți MPS, Baicu AM, Toma M, Herlea V, Iliescu L. Laparoscopic Right Adrenalectomy for a Large
   Adrenal Tumor Combined with in situ Ablation of a Hepatic Nodule in a Cirrhotic Patient. Surg.
   Gastroenterol, 2021 26:2, 151-152; DOI: 10.21614/sgo-26-2-362
5. Dodot MD, Duport-Dodot I, Toma L, Iliescu L. Key Factors Influencing qHBsAg Dynamics in Chronic
   Hepatitis B Patients During Treatment with Direct Acting Antivirals. Modern Medicine | 2020, Vol. 27, No.
   1, pag 11-18
6. Bacalbasa N, Balescu I, Diaconu CC, Iliescu L, Vilcu M, Pop L, Dimitriu M, Balalau C, Filipescu A,
   Savu C, Savu C, Belu E, Brezean I. Indocyanine green guided resection for hepatocellular carcinoma-
   literature review. Romanian Medical Journal . 2020, Vol. 67 Issue 2, p148-150.
7. Toma L, Mercan-Stanciu A, Zgura A, Bacalbasa N, Diaconu C, Iliescu L. Evolution of arterial
   hypertension in patients with hepatitis C virus cirrhosis after antiviral treatment. Journal of Advances in
   Medicine, 2020, 7(9) 1302- 1306
8. Iliescu EL, Mercan-Stanciu A, Toma L, Ioanițescu ES, Dumitru R, Rusie D, Hepatocellular
   carcinoma in the setting of interferon-free treatment for chronic HCV hepatitis -experience of a
   single center. Hepatoma Res 2018; 4:3 DOI: 10.20517/2394-5079.2017.48. ISSN 2394-5079
9. Radasan A, Voiculescu M, Iliescu L. The DAAs treatment of chronic HCV infection and the liver
   fibrosis evolution during treatment. Our experience. Romanian Journal of Infectious Diseases
   2016, 19:3 50-54. ISSN 1454-3389
10. Radasan A, Voiculescu M, Iliescu L. Non-invasive assessment of liver fibrosis using liver
    elastography (Fibroscan) in patients with chronic infection HBV and HCV. Romanian Journal of
    Infectious Diseases 2016, 19:3, 103-107. ISSN 1454 -3389
11. Iliescu L, Mindrut E, Grasu M, Orban C, Tănase A, Toma L, Popescu I. Management of
    Hepatocellular carcinioma-experience of a single center. Chirurgia (Buc.) 2014 Mar-Apr;
    109(2):204-7. ISSN: 1221-9118,
12. Iliescu L, Toma T, Orban C, Tănase A. Comorbidities of HVC infection-case report and literature
    review; Annals of Fundeni Hospital 2013, 18(1):21-26 ISSN. 1224-3450
13. Iliescu L, Toma L, Mînzală G. Triple therapy in HCV chronic hepatitis. Therapeutics
    Pharmacology and Clinical Toxicology, 2013 17:4, 207-210. ISSN 2066-0170
14. Pascu O, Voiculescu M, Gheorghe L, Micu L, Seicean A, Iliescu L, Mocan T, Ceauşu E,
    Mateescu B. Early virological response in 1220 patients with HCV (genotype lb) chronic hepatitis
    and cirrhosis treated with PegInterferonplus Ribavirin. Rom J Intern Med. 2011;49(2):105-12.
    PMID: 22303601; ISSN 1220-4749
15. Mihaila M, Micu L, Iliescu L. Cholestasis –unfavorable prognostic factor in the evolution of liver
    cirrhosis. Archives of the Balkan Medical Union, vol. 40, no. 2, June 2005, pg. 121-122
    Carti nationale/National books:
16. Laura Iliescu. Carcinomul Hepatocelular, 142 pag ISBN 978-973-712-673-3
17. Laura Iliescu. Vademecum de Medicină Internă, 663 pag, ISBN 978-973-712-804-1
18. Laura Iliescu.co-autor. In Redactor Prof. Dr. Ion Dina,
    Semiologie medicală, vol I. Editura Universitară ”Carol Davila”, 2018, pag 230-237, ISBN 978-
    606-011-002-5,
19. Laura Iliescu. Co-autor. În Redactor Prof. Dr. Ion Dina, Semiologie
    medicală, vol II. Editura Universitară ”Carol Davila”, 2018, pag 265-281, ISBN 978-606-011-002-6

Carți

Vezi mai mult

1. Co-autor Laura Iliescu. In Liver Diseases A Multidisciplinary Textbook. Editors: Radu-Ionita, F.Pyrsopoulos, N., Jinga, M., Tintoiu, I.C., Sun, Z., Bontas, E. Springer International Publishing, 2020; ISBN 978-3-030-24431-6, DOI 10.1007/978-3-030-24432-3
2. Hepatocellular carcinoma and antiviral therapies in HCV chronic infection. Laura Iliescu. In Update on Hepatitis C. IntechOpen. Edited by Prof. Luis Rodrigo. 2021 DOI: 10.5772/intechopen.96551
3. Ultrasound of the spleen Simona Ioanițescu, Laura Iliescu, Mihai Harza, Gener Ismail, Ionel Copaci. EFSUMB –European Course Book. Student Edition, 1st Edition, 2014. Editors: Jan Tuma, Radu Badea, Christoph F. Dietrich.
4. Particularities of Hepatic Sarcoidosis. Laura Iliescu, Letitia Toma. In Sarcoidosis and Granulomatosis – Diagnosis and Management. IntechOpen. Edited by Mohammad Hosein K. Motamedi. July 29th 2020.
   DOI: 10.5772/intechopen.90694
5. Laura Iliescu. Carcinomul Hepatocelular, 142 pag ISBN 978-973-712-673-3
6. Laura Iliescu. Vademecum de Medicină Internă, 663 pag, ISBN 978-973-712-804-1
7. Laura Iliescu.co-autor. In Redactor Prof. Dr. Ion Dina, Semiologie medicală, vol I. Editura Universitară ”Carol Davila”, 2018, pag 230-237, ISBN 978-606-011-002-5,
8. Laura Iliescu. Co-autor. În Redactor Prof. Dr. Ion Dina, Semiologie medicală, vol II. Editura Universitară ”Carol Davila”, 2018, pag 265-281, ISBN 978-606-011-002-6